Articles

Projected Impact on Labor Productivity Costs of Cancer Related Premature Mortality in Europe 2018–2040

Marta Ortega Ortega, Paul Hanly, Alison Pearce, et al. Applied Health Economics and Health Policy (2023) 21:877–889

Between 2018 and 2040, cancer is expected to cause around eight million premature deaths (58% male). The cumulative projected productivity costs in this respect are €1.3 trillion, representing an annual average of €58.7 billion, or 0.43% of the EU-27 gross domestic product. Labour productivity costs are projected to de... Read More

15 Apr, 2026

Prevent Cancer 2026 Survey

Cost concerns now rival fear of cancer diagnosis, new survey findsFindings from the Prevent Cancer Foundation’s 2026 Early Detection Survey reveal that concern about unexpected costs of getting routine cancer screenings now rivals the fear of getting diagnosed with cancer. More than one in three U.S. adults (34%) who w... Read More

09 Apr, 2026

Prevent Cancer Survey 2025

According to the Prevent Cancer Foundation’s 2025 Early Detection Survey, just 51% of U.S. adults 21 years of age and older say they have had a routine medical appointment or routine cancer screening in the last year.1  This is a 10-percentage point drop from the 2024 survey.The survey did reveal some encoura... Read More

06 Apr, 2026

Routine cancer screening and medical appointment behaviors

There’s been a change in how often U.S. adults are going to routine medical appointments and cancer screenings, and according to the Prevent Cancer Foundation’s 2025 Early Detection Survey, we’re moving in the wrong direction.The survey revealed just 51% of U.S. adults 21 years of age and older say they have had a... Read More

06 Apr, 2026

Potential Impact of Next-Generation Weight Loss Drugs on Cancer Incidence

Darren R. Brenner; Yibing Ruan; Chantelle Carbonell. JAMA Network Open. 2025;8(9):e2530904

Excess body size has emerged as an impactful component of population-level cancer risk. Current data suggest that at least 13 cancer sites are convincingly associated with excess body size, most often characterized by a body mass index (BMI) greater than 25.0. These results have been impressive, especially when compar... Read More

24 Mar, 2026

Association between glucagon-like peptidase 1 receptor agonist and obesity-related cancer in overweight or obese patients with type 2 diabetes: a nationwide cohort study

Xianhua Mao, Xinrong Zhang, Linda Henry, et al. JNCI: J. National Cancer Institute, 117:10, October 2025, 2053-2061

Among 919, 609 overweight or obese individuals with type 2 diabetes, 16 653 newly diagnosed with obesity-related cancer were recorded during the 2, 086 ,526 person-years of follow-up. GLP-1 agonist users (vs other glucose-lowering drugs users) were associated with lower incidence and risk of obesity-related cancer. Thi... Read More

24 Mar, 2026

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes

Lindsey Wang, Rong Xu, David C Kaelber et al. JAMA Netw Open 2024;7;(7):e2421305

Thirteen human malignant neoplasms have been identified as obesity-associated cancers (OACs), ie, the presence of excess body fat is associated with increased risk of developing cancer and worse prognosis in patients with these specific tumors. The glucagon-like peptide receptor agonist (GLP-1RA) class of pharmaceutica... Read More

24 Mar, 2026

GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity

Hao Dai; Yongqiu Li; Yao An Lee; et al. JAMA Oncol. Published online August 21, 2025

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely prescribed for glycemic control in type 2 diabetes and have recently gained popularity for weight management. We compared the incidence of 14 cancers among adults with obesity prescribed GLP-1RAs vs nonusers. A total of 86 632 matched adults were included,... Read More

24 Mar, 2026

Ultra processed Food (UPF) Consumption and Risk of Early-Onset Colorectal Cancer (EOCRC) Precursors Among Women

Chen Wang, Mengxi Du, Hanseul Kim, et al. JAMA Oncol. 2026 Jan 1;12(1):49-57

In this study, higher UPF intake was associated with increased risk of early-onset colorectal conventional adenomas. These data highlight the important role of UPFs in early-onset colorectal tumorigenesis and support improving dietary quality as a strategy to mitigate the increasing burden of EOCRC. Among 29,105 female... Read More

24 Mar, 2026

An analysis of the burden of colorectal cancer caused by high body mass index in 204 countries and regions worldwide from 1990 to 2023

Zeyu Wu, Yuncan Xing, Fangze Wei,et al. J Glob Health. 2026 Feb 27:16:04043

Colorectal cancer (CRC) remains a leading global malignancy with a rising obesity-attributable burden. Emerging evidence highlights concerning trends in early-onset CRC and marked regional disparities, underscoring the need for comprehensive epidemiological assessments to inform targeted prevention strategies. From 199... Read More

24 Mar, 2026